These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19634640)

  • 41. Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.
    Khan MH; Okumura J; Sovannarith T; Nivanna N; Akazawa M; Kimura K
    Trop Med Int Health; 2010 May; 15(5):639-44. PubMed ID: 20214756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation.
    Gaudiano MC; Di Maggio A; Antoniella E; Valvo L; Bertocchi P; Manna L; Bartolomei M; Alimonti S; Rodomonte AL
    J Pharm Biomed Anal; 2008 Sep; 48(2):303-9. PubMed ID: 18243626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Counterfeit drugs: analytical techniques for their identification.
    Martino R; Malet-Martino M; Gilard V; Balayssac S
    Anal Bioanal Chem; 2010 Sep; 398(1):77-92. PubMed ID: 20437031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
    Taylor RB; Shakoor O; Behrens RH; Everard M; Low AS; Wangboonskul J; Reid RG; Kolawole JA
    Lancet; 2001 Jun; 357(9272):1933-6. PubMed ID: 11425415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
    Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
    BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Summary of the executive session on critical threats to the pharmacy supply chain and the effects on patient care.
    Am J Health Syst Pharm; 2013 Oct; 70(19):1689-98. PubMed ID: 24048606
    [No Abstract]   [Full Text] [Related]  

  • 48. Counterfeit medications: impurities in the american drug supply.
    Stoneman A; Simon S; Trahan J
    J Midwifery Womens Health; 2011; 56(6):636-8. PubMed ID: 22060224
    [No Abstract]   [Full Text] [Related]  

  • 49. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality assurance in proprietary medicines.
    Clarke CL
    Med Serv J Can; 1967 Mar; 23(3):277-86. PubMed ID: 6056373
    [No Abstract]   [Full Text] [Related]  

  • 52. [Update on counterfeit drugs: a growing risk for public health].
    Juillet Y
    Bull Acad Natl Med; 2008 Oct; 192(7):1423-34; discussion 1434-6. PubMed ID: 19445366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A counterfeit drug treaty: great idea, wrong implementation.
    Bate R; Attaran A
    Lancet; 2010 Oct; 376(9751):1446-8. PubMed ID: 21036261
    [No Abstract]   [Full Text] [Related]  

  • 54. [Counterfeit pharmaceuticals in Peru].
    Exebio LE; Rodríguez J; Sayritupac F
    Rev Panam Salud Publica; 2010 Feb; 27(2):138-43. PubMed ID: 20339618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Methodology for Identification of Inverse Drug Distribution, Spain].
    López Pérez MA; Muñoz Arias M; Vázquez Mourelle R
    Rev Esp Salud Publica; 2016 Apr; 90():E8. PubMed ID: 27041080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of illegal trade on the quality of epoetin alfa in Thailand.
    Fotiou F; Aravind S; Wang PP; Nerapusee O
    Clin Ther; 2009 Feb; 31(2):336-46. PubMed ID: 19302906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973
    [No Abstract]   [Full Text] [Related]  

  • 58. The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania.
    Kaale E; Manyanga V; Chambuso M; Liana J; Rutta E; Embrey M; Layloff T; Johnson K
    PLoS One; 2016; 11(11):e0165785. PubMed ID: 27846216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Does medicine lose its value near the expiration date?].
    Török I
    Acta Pharm Hung; 2001 Aug; 71(2):213-4. PubMed ID: 11862672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Counterfeiting of medicinal drugs: issues and threats.
    Juillet Y; Vlasto AP
    Fundam Clin Pharmacol; 2005 Dec; 19(6):621-4. PubMed ID: 16313273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.